Literature DB >> 11039134

Inhibitory effect of meconium on pulmonary surfactant function tested in vitro using the stable microbubble test.

M H Oh1, C W Bae.   

Abstract

UNLABELLED: Meconium aspiration syndrome is related to mechanical obstruction of the airways and subsequent chemical pneumonitis. It has also been suggested that meconium causes inhibition of surfactant function. To assess its inhibitory effect on surfactant function in vitro, we used a stable microbubble (SM) test that was thought to reflect the adequacy of pulmonary surfactant. The mixtures were prepared by adding serial dilutions of human meconium to various concentrations of Surfactant-TA (Surfacten). The SM count at each concentration of surfactant significantly increased with the increasing concentration of surfactant. This shows that the SM test closely reflects the quantified function of surfactant. When various concentrations of meconium were added to the surfactant concentration of 0.05 mg/ml and 0.25 mg/ml, the SM test results were decreased even at low concentrations of meconium. Also the increase in the meconium concentration caused a decrease in the SM test result, which was dependent on the surfactant and the meconium concentration, accordingly. These results suggest that meconium inhibits surfactant function.
CONCLUSION: The stable microbubble test is an effective indirect method that tests the changes in surfactant quantity. In the in vitro experiment, we observed an inhibitory effect of meconium on the surfactant activity using the stable microbubble test.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039134     DOI: 10.1007/pl00008344

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  3 in total

1.  Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids.

Authors:  Elena Lopez-Rodriguez; Mercedes Echaide; Antonio Cruz; H William Taeusch; Jesus Perez-Gil
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

Review 2.  Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?

Authors:  Emmanuel Lopez; Géraldine Gascoin; Cyril Flamant; Mona Merhi; Pierre Tourneux; Olivier Baud
Journal:  BMC Pediatr       Date:  2013-10-10       Impact factor: 2.125

Review 3.  Techniques to evaluate surfactant activity for a personalized therapy of RDS neonates.

Authors:  Chiara Autilio
Journal:  Biomed J       Date:  2021-11-07       Impact factor: 4.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.